Renes Kahn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Renes Kahn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Renes Kahn Today - Breaking & Trending Today

Olanzapine/Samidorphan Maintains Mood Disorder Efficacy, Weight and Glycemic Tolerability at 4 Years

Published: May 4, 2024

Four-year, phase 3 data from APA 2024 show olanzapine/samidorphan provided consistent antipsychotic efficacy and weight-related safety in patients with either schizophrenia or bipolar I disorder.

Source: hcplive.com

Related Topics:

United StatesNew YorkRenes KahnIcahn School Of Medicine Mount SinaiAmerican Psychiatric AssociationIcahn SchoolMount SinaiClinical Global Impressions SeverityAapa 2024Mood DisorderBipolar Disorder